We are live on ! Find out more
GDNRU

Gardiner Healthcare Acquisitions Corp. Unit

Delisted

GDNRU was delisted on the 15th of November, 2023.

1 hedge funds and large institutions have $3.49K invested in Gardiner Healthcare Acquisitions Corp. Unit in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 21 (-1)

99% less capital invested

Capital invested by funds: $331K → $3.49K (-$328K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
YCM
Yakira Capital Management
Connecticut
-$328K

GDNRU Hedge Fund Activity: Q2 2023 in Review

1 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Gardiner Healthcare Acquisitions Corp. Unit (GDNRU) for Q2 2023, worth a combined $3.49K — down 99% from $331K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of GDNRU and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Yakira Capital Management, exiting entirely with an estimated $328K sold.

  • 1 institutional investor held Gardiner Healthcare Acquisitions Corp. Unit (GDNRU) as of Q2 2023, down from 2 in Q1 2023.
  • Funds reported $3.49K of Gardiner Healthcare Acquisitions Corp. Unit stock for Q2 2023, down 99% quarter-over-quarter.
  • 0 funds opened new Gardiner Healthcare Acquisitions Corp. Unit positions in Q2 2023 and 1 closed out, a net change of -1 holder.
  • The largest Gardiner Healthcare Acquisitions Corp. Unit seller in Q2 2023 was Yakira Capital Management, an estimated $328K sold.

Based on aggregated 13F filings for Q2 2023.